Latest Funding News

Vitasora Health Limited reported robust patient program growth and secured new US partnerships, driving revenue above A$1 million for the quarter. A recent A$11 million capital raise positions the company for continued expansion and cash-flow breakeven by late 2026.

Winchester Energy reported a slight dip in production but secured a strategic 30% farm-out deal for its Varn waterflood project, alongside significant board restructuring.

Korvest has reported a record $13.2 million profit for FY25, driven by strong performances in its EzyStrut and Galvanising divisions, and is now embarking on a major expansion of its Kilburn manufacturing site.

Simble Solutions reports new multi-year contracts in the UK and Australia, boosting revenue prospects, but faces a cash runway of less than one quarter and is exploring funding options.

NoviqTech Limited has launched Fuel Central for sustainable fuels traceability and established Quantum Intelligence Pty Ltd to advance quantum computing and AI applications, backed by a $1.08 million placement. The company also refreshed its board and expanded its international footprint.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

Cadoux Limited has made significant progress in its High Purity Alumina (HPA) front-end engineering design and advanced the Minhub rare earths feasibility study, positioning itself strongly in the evolving critical minerals market.

Metgasco’s latest quarterly report reveals a 24% drop in sales revenue amid ongoing Production Uplift Program activities, while reserves remain stable and strategic farm-out talks advance.

Anson Resources has inked a key lithium supply deal with LG Energy Solution and made significant progress on its Green River Lithium Project in Utah, backed by a $5 million capital raise.

ADX Energy reports a 17% production dip in Q3 2025 due to well downtime but boosts sales revenue by 23%, while advancing drilling plans and acquiring key infrastructure.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.

Linius Technologies has implemented a sweeping operational restructure, cutting expenses by more than 60% compared to FY25, while progressing a pivotal proof of concept with a major European football league and securing over $3.7 million in new funding.